Skip to main content
锦波生物 logo

锦波生物 — Investor Relations & Filings

Ticker · 920982 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 391 across all filing types
Latest filing 2025-08-20 Governance Information
Country CN China
Listing Beijing Stock Exchange 920982

About 锦波生物

https://www.sxjbswyy.com/

Shanxi Jinbo Bio-Pharmaceutical Co., Ltd. specializes in the research, development, and manufacturing of functional proteins through synthetic biology. The company is recognized for its industrialization of recombinant humanized collagen, specifically Type III collagen with a stable triple helix structure. Its core business encompasses the production of medical-grade biomaterials, functional skincare products, and medical devices used in aesthetics, wound healing, and gynecological health. By utilizing advanced protein engineering, the company provides biocompatible solutions designed for tissue repair and anti-aging applications. Its technical focus remains on the structural optimization and large-scale production of high-purity recombinant proteins to meet clinical and consumer health demands.

Recent filings

Filing Released Lang Actions
董事、高级管理人员持股变动管理制度
Governance Information Classification · 95% confidence The document is titled '董事、高级管理人员持股变动管理制度' which translates to 'Management System for Shareholding Changes of Directors and Senior Management'. It details internal rules and regulations regarding shareholding and share transactions by directors and senior management, including restrictions, reporting obligations, and compliance with relevant laws and stock exchange rules. It is a governance-related document focusing on internal control and compliance regarding shareholding changes by key personnel. There is no indication of financial data, audit results, earnings, or meeting materials. It is not an announcement of a report but a detailed policy document. Therefore, the document fits best under Governance Information (CGR).
2025-08-20 Chinese
关于取消监事会并修订《公司章程》的公告
Governance Information Classification · 95% confidence The document is a detailed announcement regarding the cancellation of the supervisory board and amendments to the company's articles of association (公司章程). It includes extensive revisions to the company's governance structure, shareholder rights, board responsibilities, and related corporate governance matters. The content focuses on internal company rules, board and shareholder meeting procedures, and compliance with relevant laws and stock exchange regulations. There is no indication of financial statements, audit results, earnings data, or other financial performance disclosures. The document is not a report of financial results or an announcement of voting outcomes but rather a governance-related disclosure. Therefore, the document best fits the category of Governance Information (CGR).
2025-08-20 Chinese
重大信息内部报告制度
Governance Information Classification · 95% confidence The document is titled '重大信息内部报告制度' which translates to 'Major Information Internal Reporting System'. It details the internal procedures, responsibilities, and definitions related to the reporting and management of major information within the company. It includes sections on the scope of major information, reporting procedures, confidentiality obligations, and penalties for non-compliance. There is no financial data, earnings information, or shareholder voting results. It is a governance-related document outlining internal rules and processes for information disclosure. Therefore, it fits best under Governance Information (CGR). The document length is 4539 characters, which is substantial and contains detailed governance content, not just an announcement or summary.
2025-08-20 Chinese
中信证券股份有限公司关于山西锦波生物医药股份有限公司使用闲置募集资金购买理财产品的核查意见
Regulatory Filings Classification · 87% confidence The document is a sponsor (保荐机构) due diligence opinion on the use of idle IPO proceeds to purchase wealth management products, prepared under Beijing Stock Exchange listing rules. It is not an annual or interim financial report, earnings release, or management discussion; nor is it merely an announcement of report publication. It is a compliance/regulatory filing presenting the sponsor’s assurance and legal conformity, making it a general regulatory announcement. Falls under the fallback category "Regulatory Filings (RNS)."
2025-08-20 Chinese
董事会议事规则
Governance Information Classification · 95% confidence The document is titled '董事会议事规则' which translates to 'Board Meeting Rules' and details the internal governance rules and procedures for the company's board of directors. It includes sections on board composition, powers, meeting procedures, voting rules, and record-keeping. There is no financial data, earnings information, or audit content. The document is a formal governance document outlining internal rules and practices for the board. It is not an announcement of a report, nor a report itself. Therefore, it fits the category of Governance Information (CGR). The document length (7552 characters) supports it being a full governance document rather than a brief announcement or certification.
2025-08-20 Chinese
对外投资管理制度
Governance Information Classification · 95% confidence The document is titled '对外投资管理制度' which translates to 'External Investment Management System' and details the company's internal policies and procedures regarding external investments. It includes sections on decision-making processes, financial management, auditing, personnel management, and information disclosure related to external investments. The document is a formal announcement of the adoption and revision of internal governance policies by the company's board and shareholders. It does not contain financial statements, earnings data, or audit results, nor is it a transcript or presentation. It is a governance-related document outlining internal rules and procedures. Therefore, it fits best under Governance Information (CGR). The document length is 4388 characters, which is relatively short but contains substantive policy content rather than just an announcement of a report publication, so it is not RPA or RNS.
2025-08-20 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.